Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens

Lancet

Volumn 354, Issue 9190, 1999, Pages 1604-1607

  Jehle, Peter M ^a   Micheler, Clemens ^c   Jehle, Daniela R ^a   Breitig, Dieter ^c   Boehm, Bernhard O ^b  

^a Division of Nephrology   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PROTAMINE;

ADULT; AGED; ARTICLE; DIABETES CONTROL; DRUG DELIVERY SYSTEM; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0033530471     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)12459-5     Document Type: Article

References (21)

1. Reichard P., Nilsson B.Y., Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 329:1993;304-309.
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent mellitus. N Engl J Med. 329:1993;977-986.
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 352:1998;837-853.
4. Murray D.P., Keenan P., Gayer E.et al. A randomized trial of the efficacy and acceptability of a pen injector. Diabet Med. 5:1988;750-754.
5. Insulin pen: mightier than syringe? Lancet. i:1989;307-308.
6. Clinical practice recommendations: insulin administration. Diabetes Care. 21(suppl 1):1998;72-75.
7. Buysschaert M., Janne P., Mpoy M.et al. Metabolic and psychological evolution of insulin dependent diabetic patients during a 6 months insulin-pen treatment. Diabetes Metab. 14:1988;75-79.
8. Dinneen S.F., Cronin C.C., O'Sullivan D.J. Long term efficacy of a pen injector. Ir J Med Sci. 160:1991;286-287.
9. Ginsberg B.H., Parkes J.L., Sparacino C. The kinetics of insulin administration by insulin pens. Horm Metab Res. 26:1994;584-587.
10. Hardy K.J., Jones K.E., Gill G.V. Deterioration in blood glucose control in females with diabetes changed to a basal-bolus regimen using a pen-injector. Diabet Med. 8:1991;69-71.
11. Jorgensen J.O., Flyvbjerg A., Jorgensen J.T., Sorensen H.H., Johansen B.R., Christiansen J.S. NPH insulin administration by means of a pen injector. Diabet Med. 5:1988;574-576.
12. Buysschaert M., Lambert A.E. The insulin pen. Lancet. i:1989;965.
13. Fisken R.A., Goulbourn J. Treatment of insulin-dependent diabetes using an injection pen: control, problems and patients preferences. Diabetes Res. 11:1989;195-197.
14. Chase H.P., Garg S.K., Hoops S.L., Harris S., Wilcox W. Use of the pen delivery system for intensive insulin therapy in college-age students with type I diabetes. J Adolesc Health. 12:1991;373-376.
15. Andersson P.O., Wilkby A., Stenstrom U., Hornquist J.O. Pen injection and change in metabolic control and quality of life in insulin dependent diabetes mellitus. Diabetes Res Clin Pract. 36:1997;169-172.
16. Steinemann M.A., Zuppinger K. Basal bolus therapy in adolescent diabetic patients. Ther Umsch. 47:1990;22-29.
17. Bak J.F., Nielsen O.H., Pedersen O., Beck-Nielsen H. Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients. Diabetes Res. 6:1987;155-158.
18. Chantelau E., Schiffers T., Schutze J., Hansen B. Effects of patient-selected intensive insulin therapy on quality of life. Patient Educ Couns. 30:1997;167-173.
19. Skyler J.S. Insulin pharmacology. Med Clin North Am. 72:1988;1337-1354.
20. Berger M., Cüppers H.J., Hegner H., Jörgens C., Berchtold P. Absorption kinetics and biological effects of subcutaneously injected insulin preparations. Diabetes Care. 5:1982;77-91.
21. Brogden R.N., Heel R.C. Human insulin. Drugs. 34:1987;650-671.